Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Gnanapragasam, V. J."" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł :
Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].
Autorzy :
Ross-Adams H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Lamb AD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK. Electronic address: .
Dunning MJ; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Halim S; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Lindberg J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: .
Massie CM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Egevad LA; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: .
Russell R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Ramos-Montoya A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Vowler SL; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Sharma NL; Nuffield Department of Surgical Sciences, University of Oxford, Roosevelt Drive, Oxford, UK. Electronic address: .
Kay J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK. Electronic address: .
Whitaker H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK. Electronic address: .
Clark J; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: .
Hurst R; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: .
Gnanapragasam VJ; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK. Electronic address: .
Shah NC; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address: .
Warren AY; Department of Pathology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address: .
Cooper CS; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: .
Lynch AG; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Stark R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Mills IG; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Prostate Cancer Research Group, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway; Department of Molecular Oncology, Institute of Cancer Research, Oslo University Hospitals, N-0424 Oslo, Norway; Prostate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. Electronic address: .
Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: .
Neal DE; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address: .
Pokaż więcej
Corporate Authors :
CamCaP Study Group
Źródło :
EBioMedicine [EBioMedicine] 2017 Mar; Vol. 17, pp. 238. Date of Electronic Publication: 2017 Mar 08.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.
Autorzy :
Ross-Adams H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Lamb AD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK ; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK.
Dunning MJ; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Halim S; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Lindberg J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Massie CM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Egevad LA; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Russell R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Ramos-Montoya A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Vowler SL; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Sharma NL; Nuffield Department of Surgical Sciences, University of Oxford, Roosevelt Drive, Oxford, UK.
Kay J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK.
Whitaker H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK.
Clark J; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.
Hurst R; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.
Gnanapragasam VJ; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK ; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK.
Shah NC; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.
Warren AY; Department of Pathology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.
Cooper CS; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.
Lynch AG; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Stark R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Mills IG; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Prostate Cancer Research Group, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway ; Department of Molecular Oncology, Institute of Cancer Research, Oslo University Hospitals, N-0424 Oslo, Norway ; Prostate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.
Grönberg H; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK.
Neal DE; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.
Pokaż więcej
Corporate Authors :
CamCaP Study Group
Źródło :
EBioMedicine [EBioMedicine] 2015 Jul 29; Vol. 2 (9), pp. 1133-44. Date of Electronic Publication: 2015 Jul 29 (Print Publication: 2015).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Dosage*
Prostatic Neoplasms/*genetics
Transcriptome/*genetics
Adult ; Aged ; Aged, 80 and over ; Cluster Analysis ; Cohort Studies ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Genome, Human ; Humans ; Male ; Middle Aged ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Recurrence ; Reproducibility of Results ; Risk Factors
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies